These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15548159)

  • 41. Pregnancy in a woman with premature ovarian insufficiency undergoing intracytoplasmic sperm injection after pretreatment with estrogens followed by therapy with estrogens associated with ovarian stimulation with gonadotropins: remarks about oocyte and embryo quality.
    Tartagni M; Damiani GR; Di Naro E; Persiani P; Crescini C; Loverro G
    Menopause; 2011 Aug; 18(8):932-4. PubMed ID: 21552164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimizing assisted reproduction: impact of low-dose gonadotropin-releasing hormone agonist on in vitro fertilization outcome.
    Lenton E; Mohamed K
    Fertil Steril; 2005 Dec; 84(6):1783-5. PubMed ID: 16359992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ovarian stimulation for in vitro fertilization in patients with endometriosis.
    Zikopoulos K; Kolibianakis EM; Devroey P
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):651-5. PubMed ID: 15225190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial.
    Fatemi HM; Kolibianakis EM; Camus M; Tournaye H; Donoso P; Papanikolaou E; Devroey P
    Hum Reprod; 2006 Oct; 21(10):2628-32. PubMed ID: 16857887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [GnRH antagonists in natural cycles].
    Frydman R
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S46-9. PubMed ID: 15643689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles.
    Tesarik J; Hazout A; Mendoza-Tesarik R; Mendoza N; Mendoza C
    Hum Reprod; 2006 Oct; 21(10):2572-9. PubMed ID: 16926261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [How to prevent completely ovarian hyperstimulation with GnRH-based stimulation protocols].
    Kol S
    Akush Ginekol (Sofiia); 2001; 40(4):36-41. PubMed ID: 11803870
    [No Abstract]   [Full Text] [Related]  

  • 48. Folliculogenesis, embryo parameters and post-transfer recipient pregnancy rate following equine follicle-stimulating hormone (eFSH) treatment in cycling donor mares.
    Raz T; Green GM; Carley SD; Card CE
    Aust Vet J; 2011 Apr; 89(4):138-42. PubMed ID: 21418170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Combined GnRH analogs/hMG/hCG treatment].
    Braendle W
    Arch Gynecol Obstet; 1989; 245(1-4):931-5. PubMed ID: 2529828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extension of GnRH agonist through the luteal phase to improve the outcome of intracytoplasmic sperm injection.
    Isikoglu M; Ozgur K; Oehninger S
    J Reprod Med; 2007 Jul; 52(7):639-44. PubMed ID: 17847764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sperm to zona pellucida binding depends on the use of a gonadotropin-releasing hormone agonist or a gonadotropin-releasing hormone antagonist.
    Schröder AK; Schöpper B; Al-Hasani S; Löning M; Diedrich K; Ludwig M
    Fertil Steril; 2003 Mar; 79(3):648-50. PubMed ID: 12620461
    [No Abstract]   [Full Text] [Related]  

  • 54. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
    Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
    Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of GnRH analog for induction of the ovulatory surge of gonadotropins in patients at risk of the ovarian hyperstimulation syndrome.
    Kulikowski M; Wołczyński S; Kuczyński W; Grochowski D; Szamatowicz M
    Gynecol Endocrinol; 1995 Jun; 9(2):97-102. PubMed ID: 7502696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
    Barad DH; Weghofer A; Gleicher N
    Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low AMH and GnRH-antagonist strategies.
    Nelson SM; Fleming R
    Fertil Steril; 2009 Aug; 92(2):e40; author reply e41. PubMed ID: 19580967
    [No Abstract]   [Full Text] [Related]  

  • 58. The J-Tip Needle-Free Injection System in controlled ovarian hyperstimulation in in vitro fertilization: a pilot study.
    Lavery SA; El-Shawarby SA; Turner C; Trew G
    Fertil Steril; 2008 Nov; 90(5):1969-72. PubMed ID: 18166182
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical application of gonadotrophin for IVF-ET].
    Kajihara T; Ishihara O
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():237-41. PubMed ID: 16689315
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916).
    Safdarian L; Mohammadi FS; Alleyassin A; Aghahosseini M; Meysamie A; Rahimi E
    Hum Reprod; 2007 Sep; 22(9):2449-54. PubMed ID: 17635844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.